Adaptive Designs for Phase II Trials
The cost and time of a Phase II trial can be reduced by using a successful adaptive design.
An adaptive phase II trial design can provide an earlier determination of futility and prediction of phase III success. This reduces the overall phase II and III trial sizes whilst shortening overall drug development time.
You will learn about:
- Important aspects of Phase II trial designs to consider
- Practical worked examples of:
- MCP-Mod (continuous outcome)
- MCP-Mod (binary outcome)
- Fleming GST (binary outcome)
nQuery helps make your clinical trials faster, less costly and more successful with tools for sample size calculation - refining Frequentist, Bayesian & Adaptive designs.
Start your unlimited 14-day trial to help design efficient, informative and ethical adaptive trials.
